Actinidia eriantha
Actinidia eriantha · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Actinidia eriantha is a botanical species recognized for its diverse array of bioactive chemical compounds. The plant contains significant concentrations of alcohols, polysaccharides, terpenoids, and aldehydes. Researchers focus primarily on the roots of this plant to derive medicinal benefits through various preparations, such as herbal tea. These root-based extracts have been studied for their potential role in addressing serious health conditions, including chronic hepatitis, colon cancer, hernia, and leukemia. Consequently, this species remains a subject of interest in the search for natural therapeutic agents.
- Synonyms
- Actinidia Davidii · Actinidia Eriantha F. Alba · 4 more
- Common names
- Not available
- Family
- Actinidiaceae
- Distribution
- Northern America
- Plant Parts
- Root
Classification
Common Names
Actinidia eriantha is a distinctive climbing species commonly known by the name velvetvine. This name is derived from the soft, fuzzy texture that characterizes its unique foliage. As a member of the kiwi family, it brings a touch of exotic elegance to any garden it inhabits. The plant's lush growth habit allows it to drape beautifully over trellises or fences. Understanding its identity is the first step for any gardener looking to cultivate this charming botanical treasure.
Sources: Catalogue of Life (COL)
Synonyms
Actinidia eriantha is a complex species that is frequently identified by several botanical synonyms in scientific literature. One notable synonym is Actinidia davidii, which can sometimes lead to confusion in taxonomic classifications. The plant also encompasses various forms and varieties, such as Actinidia eriantha f. alba and Actinidia eriantha var. brunnea. Furthermore, its genetic diversity is reflected in the recognition of Actinidia eriantha var. calvescens. Other related classifications include Actinidia fulvicoma var. lanata, illustrating the intricate web of relationships within this genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Actinidia eriantha is a specialized organism that belongs to the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It further occupies a specific niche as a member of the order Ericales. This botanical lineage continues through its placement within the family Actinidiaceae. Ultimately, the plant is defined by its membership in the genus Actinidia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Actinidiaceae |
| Genus | Actinidia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Actinidia eriantha is a unique botanical species primarily concentrated within the temperate regions of Asia. Its natural range is specifically centered in China, where it thrives in various ecological niches. Within this country, the plant can be found throughout the South-Central territories. Additionally, its distribution extends into the lush landscapes of Southeast China. This specific geographic footprint highlights the plant's reliance on the distinct climates found in these Chinese provinces.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Actinidia eriantha is distinguished by its characteristic growth form as a tree.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Actinidia eriantha contains a unique polysaccharide extracted from its roots that has long been utilized in traditional Chinese medicine to treat various cancers. This specific compound, known as AEPS, functions as a potent immunomodulatory agent by influencing the behavior of dendritic cells. Research indicates that AEPS promotes the phenotypic and functional maturation of these cells, which is essential for a robust immune response. By triggering the TLR2/4 and NF-κB signaling pathways, the polysaccharide effectively up-regulates key cytokines and chemokines. Ultimately, these findings suggest that AEPS holds significant potential for enhancing the efficacy of modern DC-based cancer immunotherapies.
Conditions
Actinidia eriantha is utilized in traditional medicine to treat various serious health conditions, including chronic hepatitis. The plant's medicinal properties are also applied to the treatment of cirrhosis with ascites. Furthermore, it plays a role in combating specific malignancies such as colon cancer and leukemia. In addition to these internal ailments, the plant is used to treat hernia. These diverse therapeutic applications highlight the significant pharmacological potential of the species.
Preparations
Actinidia eriantha holds significant cultural and medicinal value as it is prepared as herbal tea in Qingtian County, China. Within this local tradition, the species demonstrates the highest representativeness based on cognitive salience and frequency of citation. Additionally, the roots of Actinidia eriantha are prepared as a clinical treatment used in traditional Chinese medicine to address various cancers. Researchers have specifically studied polysaccharides derived from these roots to understand their potential as antitumor agents. This dual utilization highlights the plant's importance both as a traditional beverage and as a source of bioactive compounds from its root system.
Parts used
Actinidia eriantha possesses roots that have long been utilized in traditional Chinese medicine to treat various forms of cancer. Scientists have focused their research on a specific polysaccharide extracted from these roots, known as AEPS, due to its potential antitumor and immunomodulatory properties. Recent studies indicate that AEPS plays a crucial role in the maturation of dendritic cells, which are essential for a robust immune response. By activating the TLR2/4 and NF-κB signaling pathways, the compound promotes the production of vital cytokines and chemokines. Ultimately, these findings suggest that utilizing extracts from the roots of Actinidia eriantha could significantly enhance the effectiveness of modern cancer immunotherapies.